Views & Analysis Digital health round-up: Making a difference in brain disord... Is digital the true solution to brain disorders?
News Synchron to begin trials of world's first paralysis brain im... Funding raised by US Department of Defense, among others.
News AbbVie builds the case for ovarian cancer drug Elahere AbbVie hopes for another lift to its fast-growing ovarian cancer drug Elahere with new survival data.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
